• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症:针对高危患者的药物和非药物治疗

Osteoporosis: drug and nondrug therapies for the patient at risk.

作者信息

Gamble C L

机构信息

Cooper Clinic Osteoporosis Center, Fort Smith, AR, USA.

出版信息

Geriatrics. 1995 Aug;50(8):39-43.

PMID:7635326
Abstract

Preventing bone loss and avoiding fractures are the most effective therapies for osteoporosis. Nondrug measures include weight-bearing exercise, adequate calcium intake, and the prevention of falls. Estrogen replacement therapy can protect bone from rapid demineralization typical of the early post-menopausal period. New research has provided more data on estrogen's safety and efficacy. Calcitonin is an option when estrogen is contraindicated. Although calcitonin requires frequent injections, it does provide some analgesic effect for patients with osteoporosis-related fracture. Fluoride and etidronate have shown promise but remain investigational due to questions about long-term effects on bone mass. Potent third-generation bisphosphonates are being studied and may be available soon.

摘要

预防骨质流失和避免骨折是治疗骨质疏松症最有效的方法。非药物措施包括负重锻炼、充足的钙摄入以及预防跌倒。雌激素替代疗法可以保护骨骼,防止绝经后早期典型的快速脱矿质。新的研究提供了更多关于雌激素安全性和有效性的数据。当雌激素禁忌时,降钙素是一种选择。尽管降钙素需要频繁注射,但它确实能为患有骨质疏松症相关骨折的患者提供一定的镇痛效果。氟化物和依替膦酸盐已显示出前景,但由于对骨量的长期影响存在疑问,仍在研究中。强效第三代双膦酸盐正在研究中,可能很快就会上市。

相似文献

1
Osteoporosis: drug and nondrug therapies for the patient at risk.骨质疏松症:针对高危患者的药物和非药物治疗
Geriatrics. 1995 Aug;50(8):39-43.
2
[Indications and limitations of non-hormonal treatments of osteoporosis].[骨质疏松症非激素治疗的适应证与局限性]
Rev Fr Gynecol Obstet. 1993 Jul-Sep;88(7-9):419-23.
3
[Treatment of osteoporosis: current data and prospects].[骨质疏松症的治疗:当前数据与前景]
Rev Rhum Ed Fr. 1994 Dec 15;61(10 Pt 2):155S-164S.
4
[Therapeutic concepts in the treatment of postmenopausal osteoporosis].[绝经后骨质疏松症的治疗理念]
Ther Umsch. 1994 Nov;51(11):737-47.
5
Osteoporosis: new hope for the future.骨质疏松症:未来的新希望。
Int J Fertil Womens Med. 1997 Jul-Aug;42(4):245-54.
6
Prevention and treatment of osteoporosis.
Compr Ther. 1990 Mar;16(3):27-33.
7
[Differential therapy of osteoporosis--an overview based on recent findings regarding the pathogenesis].骨质疏松症的差异化治疗——基于近期发病机制研究结果的概述
Z Rheumatol. 1994 Sep-Oct;53(5):274-98.
8
Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.绝经后骨质疏松症的管理:北美更年期协会立场声明
Menopause. 2002 Mar-Apr;9(2):84-101.
9
Osteoporosis: preventive strategies.骨质疏松症:预防策略
Int J Fertil Womens Med. 1998 Mar-Apr;43(2):56-64.
10
Medical therapy of osteoporosis.
Orthop Clin North Am. 1990 Jan;21(1):109-24.

引用本文的文献

1
The Role of FNDC4 in Inflammation and Metabolism for Various Diseases.FNDC4在多种疾病的炎症和代谢中的作用
Aging Dis. 2024 May 4;16(3):1471-1482. doi: 10.14336/AD.2024.0381.
2
FNDC4 Inhibits RANKL-Induced Osteoclast Formation by Suppressing NF-B Activation and CXCL10 Expression.FNDC4 通过抑制 NF-B 激活和 CXCL10 表达抑制 RANKL 诱导的破骨细胞形成。
Biomed Res Int. 2018 May 30;2018:3936257. doi: 10.1155/2018/3936257. eCollection 2018.
3
Mechanisms of the analgesic effect of calcitonin on chronic pain by alteration of receptor or channel expression.
降钙素通过改变受体或通道表达对慢性疼痛产生镇痛作用的机制。
Mol Pain. 2017 Jan-Dec;13:1744806917720316. doi: 10.1177/1744806917720316.
4
Chronic Osteoporotic Pain in Mice: Cutaneous and Deep Musculoskeletal Pain Are Partially Independent of Bone Resorption and Differentially Sensitive to Pharmacological Interventions.小鼠慢性骨质疏松性疼痛:皮肤和深部肌肉骨骼疼痛部分独立于骨吸收,且对药物干预的敏感性不同。
J Osteoporos. 2017;2017:7582716. doi: 10.1155/2017/7582716. Epub 2017 Feb 19.